Blinatumomab is a monoclonal antibody used for the treatment of acute lymphoblastic leukemia (ALL), a type of blood cancer that affects the white blood cells. It works by binding to CD19, a protein found on the surface of B cells, and CD3, a protein found on the surface of T cells. By bringing B cells and T cells into close proximity, blinatumomab can help to activate the immune system to target and destroy cancer cells.
The global market for blinatumomab is expected to grow significantly in the coming years due to the increasing prevalence of ALL and the need for more effective treatments. ALL is the most common type of cancer in children and is also seen in adults, with an estimated 5,930 new cases diagnosed in the United States in 2021.Blinatumomab is a relatively new treatment option for ALL, having been approved by the FDA in 2014. It is typically used in patients who have relapsed or refractory disease and have not responded to other treatments. In addition, it is being investigated for use in other types of blood cancers, such as non-Hodgkin lymphoma.
Get Sample PDF Copy of Report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2142
The market for blinatumomab is highly competitive, with other monoclonal antibodies and chemotherapy agents also used for the treatment of ALL. However, blinatumomab has shown promising results in clinical trials, with a high overall response rate and the potential for long-term remission. Major players in the Blinatumomab Industry intelligence report include Amgen, which markets the drug under the brand name Blincyto, and Pfizer, which recently acquired the rights to a similar drug called rituximab. Other companies are also investing in the development of new immunotherapies for the treatment of ALL and other blood cancers.
Overall, the Blinatumomab Industry intelligence report is expected to grow in the coming years due to the increasing demand for effective treatments for ALL and other blood cancers. Ongoing research and development in the field of immunotherapy are likely to drive the development of new and more effective treatments for these diseases.
Key points:
- Blinatumomab is a monoclonal antibody used for the treatment of acute lymphoblastic leukemia (ALL), a type of blood cancer that affects the white blood cells.
- The global Blinatumomab Industry intelligence report is expected to grow significantly in the coming years due to the increasing prevalence of ALL and the need for more effective treatments.
- Blinatumomab works by binding to CD19 and CD3 proteins found on the surface of B cells and T cells, respectively, to activate the immune system to target and destroy cancer cells.
- Blinatumomab is a relatively new treatment option for ALL, having been approved by the FDA in 2014, and is typically used in patients who have relapsed or refractory disease.
- The market for blinatumomab is highly competitive, with other monoclonal antibodies and chemotherapy agents also used for the treatment of ALL.
- Major players in the blinatumomab market include Amgen, which markets the drug under the brand name Blincyto, and Pfizer, which recently acquired the rights to a similar drug called rituximab.
- Ongoing research and development in the field of immunotherapy are likely to drive the development of new and more effective treatments for ALL and other blood cancers.
- The market for blinatumomab is expected to continue to grow, with increasing demand for effective treatments for ALL and other blood cancers driving innovation and competition in the field.
Get Sample PDF Copy of Report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/2142
Market Segmentation:
By Product Type:
- Prefilled
- Non-prefilled
By Application:
- Hospital
- Pharmacy
Regional scope:
- North America– U.S., Canada
- Europe– UK, Germany, Spain, France, Italy, Russia, Rest of Europe
- Asia Pacific– Japan, India, China, South Korea, Australia, Rest of Asia-Pacific
- Latin America– Brazil, Mexico, Argentina, Rest of Latin America
- Middle East & Africa– South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Other related Reports:
About Prophecy Market Insights:
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
📞+1 860 531 2574
✉ Email– sales@prophecymarketinsights.com
🌐 Website- www.prophecymarketinsights.com
Follow us on: